- Home
- KTOS vs AXSM Comparison
KTOS vs AXSM Comparison
Compare KTOS & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KTOS | AXSM |
|---|---|---|
| Founded | 1994 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.1B | 10.4B |
| IPO Year | 1999 | 2015 |
Fundamental Metrics
Financial Performance| Metric | KTOS | AXSM |
|---|---|---|
| Price | $38.07 | $155.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 24 | 22 |
| Target Price | $98.33 | ★ $282.54 |
| AVG Volume (30 Days) | ★ 4.0M | 776.4K |
| Earning Date | 11-03-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 18.18 | ★ 38.56 |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $751,900,000.00 | N/A |
| Revenue This Year | $33.27 | $49.19 |
| Revenue Next Year | $23.82 | $59.42 |
| P/E Ratio | $430.73 | ★ N/A |
| Revenue Growth | ★ 12.44 | N/A |
| 52 Week Low | $37.84 | $123.50 |
| 52 Week High | $134.00 | $260.19 |
Technical Indicators
Market Signals| Indicator | KTOS | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 27.86 | 26.68 |
| Support Level | N/A | $152.83 |
| Resistance Level | $50.59 | $169.11 |
| Average True Range (ATR) | 1.88 | 6.21 |
| MACD | -0.07 | -0.30 |
| Stochastic Oscillator | 9.35 | 4.60 |
Price Performance
Historical ComparisonAbout KTOS Kratos Defense & Security Solutions Inc.
Kratos Defense & Security Solutions Inc develops and fields transformative, affordable technology, platforms, and systems. The company has two segments; The Kratos Government Solutions (KGS) segment is comprised of an aggregation of KGS operating segments, including its microwave electronic products, space, training, and cybersecurity, C5ISR/modular systems, turbine technologies, and defense and rocket support services operating segments and The Unmanned Systems segment consists of unmanned aerial, unmanned ground, unmanned seaborne and related command, control, and communications system businesses. The company derives a majority of its revenue from the Kratos Government Solutions segment.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.